Top Markets
Coin of the day
HTG Molecular Diagnostics, Inc. HTG Molecular Diagnostics, Inc.

HTG Molecular Diagnostics, Inc.

HTGM
Kedudukan dalam Saham #28757
Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences... Based in Tucson, Arizona, HTG Molecular Diagnostics, Inc. is a life sciences company dedicated to advancing precision medicine. They provide a comprehensive suite of products, including specialized instruments, assay kit consumables, and software solutions, all designed to automate sample processing and accurately profile various molecular targets. Their extensive portfolio features numerous molecular profiling panels, such as the HTG Transcriptome Panel, HTG EdgeSeq precision immuno-oncology panel, HTG EdgeSeq miRNA whole-transcriptome assay, HTG EdgeSeq DLBCL cell of origin assay (available in both EU and non-EU versions), HTG EdgeSeq Oncology Biomarker Panel, HTG EdgeSeq ALKPlus assay EU, HTG EdgeSeq Pan B-Cell Lymphoma Panel, HTG immune response panel, and HTG mouse mRNA tumor response panel. The company directly distributes its instruments and consumables across the United States and Europe, while utilizing distributors for other international markets and specific European regions. Their diverse clientele includes biopharmaceutical companies, academic research centers, and molecular testing laboratories. Additionally, HTG Molecular Diagnostics, Inc. maintains a governing agreement with QIAGEN Manchester Limited. The company was founded in 1997 as HTG, Inc., and officially changed its name to HTG Molecular Diagnostics, Inc. in March 2011.
Harga Saham
$0.48
Disegerakkan terakhir: 2023-06-14
Modal Pasaran
$24.79M
Perubahan (1 hari)
-20.00%
Perubahan (1 tahun)
0.00%
Negara
US
Perdagangan HTG Molecular Diagnostics, Inc. (HTGM)

Kategori

Pendapatan untuk HTG Molecular Diagnostics, Inc. (HTGM)
Pendapatan pada 2026 TTM: 0
Menurut laporan kewangan terkini HTG Molecular Diagnostics, Inc., pendapatan semasa syarikat ialah 0. Pada tahun 2026, syarikat memperoleh pendapatan sebanyak 0, sama dengan pendapatan pada tahun 2026 yang berjumlah 0. Pendapatan yang dipaparkan di halaman ini adalah pendapatan sebelum faedah dan cukai atau dikenali sebagai EBIT.
Sejarah pendapatan bagi HTG Molecular Diagnostics, Inc. dari 2026 hingga 2026
Pendapatan pada akhir setiap tahun
Tahun Pendapatan Ubah
Tidak cukup data untuk tarikh yang disediakan.
Pendapatan untuk syarikat atau pesaing serupa
Syarikat Pendapatan Perbezaan Pendapatan Negara
$7.61B -
US
$4.76B -
US
- -
CN
$-252.70M -
US
$1.42B -
US